DBT supports marker discovery research and technology development through targeted initiatives, participation in broad-ranging NCI and NIH-wide initiatives, small business grants (http://grants.nih.gov/grants/funding/sbir.htm) and investigator initiated grants. DBT supports individual projects as well as large, comprehensive efforts. DBT provides support for investigators from fields not traditionally related to cancer or clinical biology, e.g. engineers, mathematicians, informatics specialists and physicists. DBT encourages and provides support for the integration of diverse teams of investigators who can link clinical and technical expertise to integrate biomarkers with technologies to develop, adapt, or enhance devices that will be useful to the clinical cancer research community.
For information on how to apply for grant support for marker discovery research and technology development projects or for more information on technology development in the Cancer Diagnosis Program, search for relevant Techonology Development Initiatives or contact DBT.
Current programs and areas of focus include